Skip to main content

Table 1 Base data of patients.

From: Maternal smoking promotes chronic obstructive lung disease in the offspring as adults

Parameter

Non-Exacerbaters (NE)

> 1 Exacerbation (1E)

Statistics/test used

Patient number

n = 133

n = 158

 

Age (y)*

67 ± 10

67 ± 10

P = 0.615/t-test

Gender (n, women/men)

45/85

50/107

P = 0.678/χ2-test

Age* at beginning of cigarette smoking

19 ± 5

20 ± 6

P = 0.652/t-test

Pack years

36.5 ± 20.6

37.9 ± 24.1

P = 0.371/t-test

Non-smoking since years (before interview)

13.2 ± 12.0

12.2 ± 9.9

P = 0.154/t-test

FEV1 % predicted*

62.7 + 20.9

9 43.1 + 20.9

9 P < 0.001/t-test

FEV1 (l)

1.6 ± 0.7

1.2 ± 0.61

P < 0.001/t-test

FVC (% predicted)

73.4 ± 18.6

59.7 ± 18.1

P < 0.001/t-test

FVC (l)

2.4 ± 0.9

2.2 + 0.7

P < 0.001/t-test

FEV1/FVC (%)

62.5 ± 15.1

56.6 ± 18.0

P < 0.01/t-test

Rt$ (cm H2O/l × sec.)

0.57 ± 0.33

1.19 ± 1.29

P < 0.01/t-test

Reversibility test§

%

8.1 ± 3.5

5.71 ± 4.6

P = 0.452/t-test

Ml

110.5 ± 47.9

129.5 ± 61.3

P = 0.768/t-test

pO2 (mmHg)

66,8 ± 13,0

58,8 ± 16,2

P < 0.01/t-test

pCO2 (mmHg)

37.5 ± 5.8

42.9 ± 12.7

P < 0.01/t-test

Patients (%) reporting chronic bronchitis (WHO definition)

30.4

30.4

P = 1.000/χ2-test

pneumonias or asthma (age* < 18 y)

8.0

13.8

P = 0.165

 

13.3

10.9

P = 0.565

Beginning of exercise induced dyspnea (age, y*)

49 ± 16

46 ± 17

P = 0.186/t-test

Reported exacerbations# (n, 2003-1980)

0

3

P < 0.001/U-test

  1. Bronchitis was defined according to the World Health Organization [37].
  2. COPD exacerbation was defined as hospitalization and treatment with systemic corticosteroids or antibiotics [9, 10, 38]. $total resistance (measured with body plethysmography); *mean, #median, §tested with salbutamol (400 μg); y = years.